Daily Trades
- Dylan Jovine
A lot of folks have written in to ask my if I think Recursion Pharmaceuticals (SYM: RXRX) is still a "BUY." Shares closed Friday at $11.93, a 39% gain from our recommended price of $8.57 a share.
- Dylan Jovine
The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
- Dylan Jovine
The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
- Dylan Jovine
Let's start by closing out one of our older positions for a small profit.
- Dylan Jovine
Lot's of folks writing in today, so I figured I'd send this note to the whole group instead of to one member at a time.
- Dylan Jovine
Thanks to a new breakthrough… A new treatment for liver cancer was created in just 30 days.
- Dylan Jovine
Forbes Reports it: “Will save the lives of billions of people.” The BBC Reports: “It could spark a medical revolution.”
- Dylan Jovine
A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it.
- Dylan Jovine
At the moment, massive pharmaceutical companies are applying artificial intelligence (AI) and machine learning (ML) to drug development. With those tools, they’re creating new drugs for a range of ailments, and potential multi-billion-dollar opportunities, says Morgan Stanley.
deal of the month
Categories
Handling Market Dips: A Little Advice from a Wall Street Insider
Israel vs. Iran: The Mistake That Could Drag the U.S. into War
The Looming Threat to Nvidia and AI
Recent posts
Tags
Connect with Us
- Dylan Jovine
A lot of folks have written in to ask my if I think Recursion Pharmaceuticals (SYM: RXRX) is still a "BUY." Shares closed Friday at $11.93, a 39% gain from our recommended price of $8.57 a share.
- Dylan Jovine
The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
- Dylan Jovine
The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
- Dylan Jovine
Let's start by closing out one of our older positions for a small profit.
- Dylan Jovine
Lot's of folks writing in today, so I figured I'd send this note to the whole group instead of to one member at a time.
- Dylan Jovine
Thanks to a new breakthrough… A new treatment for liver cancer was created in just 30 days.
- Dylan Jovine
Forbes Reports it: “Will save the lives of billions of people.” The BBC Reports: “It could spark a medical revolution.”
- Dylan Jovine
A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it.
- Dylan Jovine
At the moment, massive pharmaceutical companies are applying artificial intelligence (AI) and machine learning (ML) to drug development. With those tools, they’re creating new drugs for a range of ailments, and potential multi-billion-dollar opportunities, says Morgan Stanley.
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
